Positive topline results from phase 2 recurrent ovarian cancer trial
Rare oral cancer has distinct genetic profile
New tool decodes structures and motifs of RNA
Elite immune cells lead fight against multiple myeloma
Enodia Therapeutics acquires preclinical assets from Kezar Life Sciences
Baseimmune expands into fibrosis
Capsule technology opens new window into individual cells
SteerBio launches to find curative therapy for lymphedema
Severe atopic dermatitis drug sees positive study results
Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched